Skip to content
healthcare.dev

INVOKANA

NDC 50458-141, canagliflozin, tablet, film coated, from Janssen Pharmaceuticals, Inc..

Product NDC
50458-141
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204042
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CANAGLIFLOZIN300 mg/1

Pharmacologic classes

P-Glycoprotein Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
50458-141-01504580141015 TABLET, FILM COATED in 1 BOTTLE (50458-141-01)
50458-141-105045801411010 BLISTER PACK in 1 CARTON (50458-141-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK
50458-141-305045801413030 TABLET, FILM COATED in 1 BOTTLE (50458-141-30)
50458-141-5050458014150500 TABLET, FILM COATED in 1 BOTTLE (50458-141-50)
50458-141-905045801419090 TABLET, FILM COATED in 1 BOTTLE (50458-141-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b9057d3b-b104-4f09-8a61-c61ef9d4a3f3
  • NADAC price for package 50458014130

    GET /v1/drugs/nadac/50458014130
  • NADAC price for package 50458014190

    GET /v1/drugs/nadac/50458014190

Use it

Look up 50458-141 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.